Industry Growth Insights published a new data on “Laboratory-developed Testing Market”. The research report is titled “Laboratory-developed Testing Market research by Types (Clinical Biochemistry, Critical Care, Haematology, Immunology, Microbiology, Molecular Diagnostics, Other Test Types), By Applications (Academic Institutes, Clinical Research organizations, Hospitals laboratory, Specialty Diagnostic Centers, Other Type of Facilities), By Players/Companies Adaptive Biotechnologies Corporation, Quest Diagnostics, Roche, Illumina, Qiagen, Eurofins, Guardant Health, Biotheranostics, Adaptive Biotechnologies, Rosetta Genomics, Biodesix, Helix”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Laboratory-developed Testing Market Research Report
By Type
Clinical Biochemistry, Critical Care, Haematology, Immunology, Microbiology, Molecular Diagnostics, Other Test Types
By Application
Academic Institutes, Clinical Research organizations, Hospitals laboratory, Specialty Diagnostic Centers, Other Type of Facilities
By Companies
Adaptive Biotechnologies Corporation, Quest Diagnostics, Roche, Illumina, Qiagen, Eurofins, Guardant Health, Biotheranostics, Adaptive Biotechnologies, Rosetta Genomics, Biodesix, Helix
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
234
Number of Tables & Figures
164
Customization Available
Yes, the report can be customized as per your need.
Global Laboratory-developed Testing Market Report Segments:
The global Laboratory-developed Testing market is segmented on the basis of:
Types
Clinical Biochemistry, Critical Care, Haematology, Immunology, Microbiology, Molecular Diagnostics, Other Test Types
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Academic Institutes, Clinical Research organizations, Hospitals laboratory, Specialty Diagnostic Centers, Other Type of Facilities
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Adaptive Biotechnologies Corporation
- Quest Diagnostics
- Roche
- Illumina
- Qiagen
- Eurofins
- Guardant Health
- Biotheranostics
- Adaptive Biotechnologies
- Rosetta Genomics
- Biodesix
- Helix
Highlights of The Laboratory-developed Testing Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Clinical Biochemistry
- Critical Care
- Haematology
- Immunology
- Microbiology
- Molecular Diagnostics
- Other Test Types
- By Application:
- Academic Institutes
- Clinical Research organizations
- Hospitals laboratory
- Specialty Diagnostic Centers
- Other Type of Facilities
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Laboratory-developed Testing Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Laboratory-developed testing (LDT) is a process that allows scientists to develop and test new drugs, vaccines, and other medical products in the laboratory. LDT helps ensure that new treatments are safe and effective before they are released to the public.
Some of the major companies in the laboratory-developed testing market are Adaptive Biotechnologies Corporation, Quest Diagnostics, Roche, Illumina, Qiagen, Eurofins, Guardant Health, Biotheranostics, Adaptive Biotechnologies, Rosetta Genomics, Biodesix, Helix.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Laboratory-developed Testing Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Laboratory-developed Testing Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Laboratory-developed Testing Market - Supply Chain
4.5. Global Laboratory-developed Testing Market Forecast
4.5.1. Laboratory-developed Testing Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Laboratory-developed Testing Market Size (000 Units) and Y-o-Y Growth
4.5.3. Laboratory-developed Testing Market Absolute $ Opportunity
5. Global Laboratory-developed Testing Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Laboratory-developed Testing Market Size and Volume Forecast by Type
5.3.1. Clinical Biochemistry
5.3.2. Critical Care
5.3.3. Haematology
5.3.4. Immunology
5.3.5. Microbiology
5.3.6. Molecular Diagnostics
5.3.7. Other Test Types
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Laboratory-developed Testing Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Laboratory-developed Testing Market Size and Volume Forecast by Application
6.3.1. Academic Institutes
6.3.2. Clinical Research organizations
6.3.3. Hospitals laboratory
6.3.4. Specialty Diagnostic Centers
6.3.5. Other Type of Facilities
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Laboratory-developed Testing Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Laboratory-developed Testing Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Laboratory-developed Testing Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Laboratory-developed Testing Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Laboratory-developed Testing Demand Share Forecast, 2019-2029
9. North America Laboratory-developed Testing Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Laboratory-developed Testing Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Laboratory-developed Testing Market Size and Volume Forecast by Application
9.4.1. Academic Institutes
9.4.2. Clinical Research organizations
9.4.3. Hospitals laboratory
9.4.4. Specialty Diagnostic Centers
9.4.5. Other Type of Facilities
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Laboratory-developed Testing Market Size and Volume Forecast by Type
9.7.1. Clinical Biochemistry
9.7.2. Critical Care
9.7.3. Haematology
9.7.4. Immunology
9.7.5. Microbiology
9.7.6. Molecular Diagnostics
9.7.7. Other Test Types
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Laboratory-developed Testing Demand Share Forecast, 2019-2029
10. Latin America Laboratory-developed Testing Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Laboratory-developed Testing Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Laboratory-developed Testing Market Size and Volume Forecast by Application
10.4.1. Academic Institutes
10.4.2. Clinical Research organizations
10.4.3. Hospitals laboratory
10.4.4. Specialty Diagnostic Centers
10.4.5. Other Type of Facilities
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Laboratory-developed Testing Market Size and Volume Forecast by Type
10.7.1. Clinical Biochemistry
10.7.2. Critical Care
10.7.3. Haematology
10.7.4. Immunology
10.7.5. Microbiology
10.7.6. Molecular Diagnostics
10.7.7. Other Test Types
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Laboratory-developed Testing Demand Share Forecast, 2019-2029
11. Europe Laboratory-developed Testing Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Laboratory-developed Testing Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Laboratory-developed Testing Market Size and Volume Forecast by Application
11.4.1. Academic Institutes
11.4.2. Clinical Research organizations
11.4.3. Hospitals laboratory
11.4.4. Specialty Diagnostic Centers
11.4.5. Other Type of Facilities
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Laboratory-developed Testing Market Size and Volume Forecast by Typ
11.7.1. Clinical Biochemistry
11.7.2. Critical Care
11.7.3. Haematology
11.7.4. Immunology
11.7.5. Microbiology
11.7.6. Molecular Diagnostics
11.7.7. Other Test Types
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Laboratory-developed Testing Demand Share, 2019-2029
12. Asia Pacific Laboratory-developed Testing Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Laboratory-developed Testing Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Laboratory-developed Testing Market Size and Volume Forecast by Application
12.4.1. Academic Institutes
12.4.2. Clinical Research organizations
12.4.3. Hospitals laboratory
12.4.4. Specialty Diagnostic Centers
12.4.5. Other Type of Facilities
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Laboratory-developed Testing Market Size and Volume Forecast by Type
12.7.1. Clinical Biochemistry
12.7.2. Critical Care
12.7.3. Haematology
12.7.4. Immunology
12.7.5. Microbiology
12.7.6. Molecular Diagnostics
12.7.7. Other Test Types
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Laboratory-developed Testing Demand Share, 2019-2029
13. Middle East & Africa Laboratory-developed Testing Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Laboratory-developed Testing Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Laboratory-developed Testing Market Size and Volume Forecast by Application
13.4.1. Academic Institutes
13.4.2. Clinical Research organizations
13.4.3. Hospitals laboratory
13.4.4. Specialty Diagnostic Centers
13.4.5. Other Type of Facilities
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Laboratory-developed Testing Market Size and Volume Forecast by Type
13.7.1. Clinical Biochemistry
13.7.2. Critical Care
13.7.3. Haematology
13.7.4. Immunology
13.7.5. Microbiology
13.7.6. Molecular Diagnostics
13.7.7. Other Test Types
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Laboratory-developed Testing Demand Share, 2019-2029
14. Competition Landscape
14.1. Global Laboratory-developed Testing Market: Market Share Analysis
14.2. Laboratory-developed Testing Distributors and Customers
14.3. Laboratory-developed Testing Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Adaptive Biotechnologies Corporation
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Quest Diagnostics
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Roche
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Illumina
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Qiagen
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Eurofins
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Guardant Health
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Biotheranostics
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Adaptive Biotechnologies
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Rosetta Genomics
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Biodesix
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Helix
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.2
